Abstract
Cerebrotendinous xanthomatosis (CTX) is a lipid storage disorder that causes neurological, ophthalmic, vascular, and musculoskeletal disorders due to the deposition of cholesterol in the tissues. Hence, we report clinical and imaging of a 31‐year‐old mentally retarded man with cerebellar ataxia, bilateral swelling of the posterior aspect of Achill, and infertility.
Keywords: cataracts, cerebrotendinous xanthomatosis, developmental delay, gait disorder, infertility
1. INTRODUCTION
Cerebrotendinous xanthomatosis (CTX) is a rare inherited disorder of lipid storage characterized by abnormal deposition of cholestanol and cholesterol in multiple tissues, particularly in the brain and tendons. 1 Mutations in CYP27A1 lead to a deficiency in sterol 27‐hydroxylase. 2 The deficiency of this enzyme prevents cholesterol being converted into bile acid chenodeoxycholic acid. The block in the synthesis of this bile acid creates the accumulation of bile acid pathway intermediates and cholestanol in the blood and tissues of the affected individuals. The balance between synthesis and catabolism of cholesterol should be tightly regulated to ensure normal cellular processes. 3 Up to now, more than 400 cases have been reported worldwide. 4 The clinical manifestations usually start at infancy and develop during the first and second decades of life. 4 Patients with CTX demonstrate diverse manifestations with multi‐organ involvement and an extensive range of neurological and non‐neurological symptoms. The neurological features of CTX reported in the literature include pyramidal and cerebellar signs, sensory‐motor peripheral neuropathy, intellectual disability, and dementia. Common non‐neurological disorder includes early‐onset bilateral cataract in childhood, formation of tendon xanthomas (most often in the Achilles' tendons), and diarrhea. 5 , 6 In addition, patients with CTX suffer from severe premature atherosclerosis, pulmonary involvement, and osteoporosis with repeated bone fractures. 7 A diagnosis of CTX is made based on clinical findings, biochemical testing, neuroimaging, and molecular genetic analysis. 8 , 9 This is the first report of a CTX patient with infertility due to azoospermia.
2. CASE PRESENTATION
A 31‐year‐old mentally disabled man was referred to our neurologic clinic with a gradually worsening gait disorder, impaired balance, and repeated falling episodes. The patient was the third child of consanguinity marriage. He was delivered following a normal term pregnancy with normal birthweight and height. History of atheromatous disease or intractable infantile‐onset diarrhea was not distinguished. At the age of five, he developed a blurred vision, which was diagnosed as a bilateral cataract. The patient was a school dropout due to intellectual and neuropsychiatric disability. He had developmental delays in the mental functioning and speech with a normal physical growth. At the age of 20, he developed bilateral tendinous swelling of the posterior part of the ankles that worsened over time. He complained of severe gait disturbance and ataxia since 3–4 years ago. He had frequent falling episodes resulting in multiple bone fractures. Gait disorder worsened gradually, and he started using a wheelchair. On physical examination, he had bilateral and symmetrical painless hypertrophy of the Achilles tendons (Figure 1). Neurological examination showed muscle weakness predominant in the distal muscles of upper and lower limbs (MRC score of 3 in the foot dorsiflexion and MRC score 2 in the finger adduction and abduction), hypertonia, brisk deep tendon reflexes, bilateral Babinski sign, and ankle clonus. The finger to nose was normal, but the heel to shin was abnormal bilaterally. The laboratory results were normal for the thyroid, liver, and kidney function, serum electrolytes, and triglyceride and cholesterol level. A brain magnetic resonance imaging (MRI) discovered cerebral and cerebellar atrophy, high‐intensity areas in the dentate nuclei, and symmetric hyperintensities in the cerebellar deep white matter and paraventricular white matter on T2‐weighted (T2W) and fluid‐attenuated inversion recovery (FLAIR) images with corresponding hypointensities on T1‐weighted (T1W) images (Figure 2). Ultrasonography demonstrated focal areas of hypoechogenicity on the bilateral Achilles tendons measuring 3, 7, 9, 12, and 16 mm on the right and 8, 15, 11, and 14 mm on the left side. Whole‐exome sequencing identified a homozygous splicing mutation, NM_000784: exon3: c.465C>A; (p. Tyr155*) in CYP27A1 gene compatible with a diagnosis of CTX. The patient was married, but he was infertile. Sex hormone tests were normal. Testicular ultrasound showed that the size of the testes was in the lower limit of normal range with a normal epididymis and vein plexus. Semen analysis showed azoospermia. Analysis of the most common Y chromosome microdeletions using multiplex polymerase chain reaction and gel electrophoresis showed no microdeletions in AZFa, AZFb, and AZFc sub‐regions of the long arm of chromosome Y.
FIGURE 1.

Swelling on the posterior aspect of left Achill tendon.
FIGURE 2.

Axial image of brain MRI showing bilateral FLAIR hypersignal of the dentate nuclei and periventricular.
3. DISCUSSION
Cerebrotendinous xanthomatosis is a rare autosomal recessive genetic disorder in which cholesterol cannot be converted into bile acids due to mutations in the CY27A1 gene that encodes the mitochondrial enzyme sterol 27‐hydroxylase. 3 Half of the mutations in CYP27A1 have been detected in exons 6–8, 16% in exon 2, and 14% in exon 4. 10 , 11 The mean age at onset of clinical manifestations has been reported 19 years, but most patients are diagnosed late (about 35 years). 12 In our case, the patient had developmental delays in mental functioning and speech with neuropsychiatric disorders in childhood. In terms of clinical symptoms, patients with CTX often manifest non‐neurological and neurological symptoms such as chronic diarrhea, cataracts, tendon xanthomas, ataxia, corticospinal tract involvement, and mental disorder. The initial presentation of non‐neurological symptoms in our patient was a cataract that was revealed at the age of 5 years. In this patient, a CYP27A1 mutation was identified in exon 3. The characteristic brain MRI findings are T2/FLAIR hyperintensities in the bilateral dentate nuclei, adjacent cerebellar white matter, basal ganglia, spinal cord, and periventricular white matter as well as cerebellar atrophy. Our patient had T2/FLAIR hyperintensities in the bilateral dentate nuclei, white matter alternations, and cerebellar atrophy. 13 , 14 , 15 One of the symptoms in our case was infertility, which was not reported in previous studies. The cause of infertility in this patient was non‐obstructive azoospermia due to a lack of spermatogenesis in the testicles. The sex hormones, prolactin, and testosterone levels were normal. Co‐occurrence of azoospermia in CTX patients may be due to the accumulation of cholesterol in the scrotum sac affecting spermatogenesis and the function of the male reproductive system. Cholesterol has been revealed to cause a reduction in sperm kinetics and has negative effects on Leydig and Sertoli cells secretory capacity in rabbits. Previous studies found that changed lipid metabolism in seminal plasma plays a role in male infertility. 16 , 17 , 18 Accumulation of cholesterol in tissues is one of the obvious symptoms of CTX, but the resultant functional abnormalities are unknown. The relationship between infertility and cholesterol should be further investigated since it has not been addressed so far.
4. CONCLUSION
Cerebrotendinous xanthomatosis was diagnosed based on clinical manifestations, biochemical analysis, neuroimaging, and molecular genetic investigation. One of the detected disorders in our patient was infertility. To date, no study has investigated the relationship between infertility and azoospermia with CTX. The association between CTX and infertility is unclear, but it could be coincidental. Further research is warranted to investigate the association between azoospermia and CTX.
AUTHOR CONTRIBUTION
Ali Asghar Okhovat and Narges Karimi involved in conceptualization and design, interpretation of data, manuscript writing, and final approval of manuscript. Sima Naeini and Zahra Amiri involved in gathering data and examining the patient.
FUNDING INFORMATION
This study was not funded.
CONFLICT OF INTEREST
There is no conflict of interest. We declare that none of the authors listed on the manuscript are employed by a government agency that has a primary function other than research and/or education. None of the authors is submitting this manuscript as an official representative or on behalf of the government.
CONSENT
The authors confirmed that the signed consent was obtained from patient in accordance with the journal's patient consent policy.
ACKNOWLEDGMENT
We would like to thank the patient who agreed to participate in this intervention and gave written consent for the publication.
Karimi N, Amiri Z, Naeini S, Okhovat AA. Cerebrotendinous xanthomatosis and infertility: A case report. Clin Case Rep. 2022;10:e06661. doi: 10.1002/ccr3.6661
DATA AVAILABILITY STATEMENT
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
REFERENCES
- 1. Berginer VM, Salen G, Shefer S. Cerebrotendinous xanthomatosis. Neurol Clin. 1989;7(1):55‐74. [PubMed] [Google Scholar]
- 2. Björkhem I. Cerebrotendinous xanthomatosis. Curr Opin Lipidol. 2013;24(4):283‐287. doi: 10.1097/MOL.0b013e328362df13 [DOI] [PubMed] [Google Scholar]
- 3. Cali JJ, Hsieh CL, Francke U, Russell DW. Mutations in the bile acid biosynthetic enzyme sterol 27‐hydroxylase underlie cerebrotendinous xanthomatosis. J Biol Chem. 1991;266(12):7779‐7783. [PMC free article] [PubMed] [Google Scholar]
- 4. Stelten BML, Dotti MT, Verrips A, et al. Expert opinion on diagnosing, treating and managing patients with cerebrotendinous xanthomatosis (CTX): a modified Delphi study. Orphanet J Rare Dis. 2021;16(1):353. doi: 10.1186/s13023-021-01980-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Atallah I, Millán DS, Benoît W, Campos‐Xavier B, Superti‐Furga A, Tran C. Spinal cerebrotendinous xanthomatosis: a case report and literature review. Mol Genet Metab Rep. 2021;26:100719. doi: 10.1016/j.ymgmr.2021.100719 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. van Heijst AF, Wevers RA, Tangerman A, Cruysberg JR, Renier WO, Tolboom JJ. Chronic diarrhoea as a dominating symptom in two children with cerebrotendinous xanthomatosis. Acta Paediatr. 1996;85(8):932‐936. doi: 10.1111/j.1651-2227.1996.tb14189.x [DOI] [PubMed] [Google Scholar]
- 7. Nie S, Chen G, Cao X, Zhang Y. Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management. Orphanet J Rare Dis. 2014;9:179. doi: 10.1186/s13023-014-0179-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Patni N, Wilson DP. Cerebrotendinous xanthomatosis. In: Feingold KR, Anawalt B, Boyce A, et al., eds. Endotext. MDText.com, Inc.; 2000. Accessed November 21, 2021. http://www.ncbi.nlm.nih.gov/books/NBK395578/ [Google Scholar]
- 9. Mignarri A, Gallus GN, Dotti MT, Federico A. A suspicion index for early diagnosis and treatment of cerebrotendinous xanthomatosis. J Inherit Metab Dis. 2014;37(3):421‐429. doi: 10.1007/s10545-013-9674-3 [DOI] [PubMed] [Google Scholar]
- 10. Schneider H, Lingesleben A, Vogel HP, Garuti R, Calandra S. A novel mutation in the sterol 27‐hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. Orphanet J Rare Dis. 2010;5:27. doi: 10.1186/1750-1172-5-27 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Lorbek G, Lewinska M, Rozman D. Cytochrome P450s in the synthesis of cholesterol and bile acids–from mouse models to human diseases. FEBS J. 2012;279(9):1516‐1533. doi: 10.1111/j.1742-4658.2011.08432.x [DOI] [PubMed] [Google Scholar]
- 12. Pilo‐de‐la‐Fuente B, Jimenez‐Escrig A, Lorenzo JR, et al. Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey. Eur J Neurol. 2011;18(10):1203‐1211. doi: 10.1111/j.1468-1331.2011.03439.x [DOI] [PubMed] [Google Scholar]
- 13. Mehta BP, Shmerling RH. Teaching neuroimage: cerebrotendinous xanthomatosis. Neurology. 2008;71(2):e4. doi: 10.1212/01.wnl.0000316806.01406.74 [DOI] [PubMed] [Google Scholar]
- 14. Vanrietvelde F, Lemmerling M, Mespreuve M, Crevits L, De Reuck J, Kunnen M. MRI of the brain in cerebrotendinous xanthomatosis (van Bogaert‐Scherer‐Epstein disease). Eur Radiol. 2000;10(4):576‐578. doi: 10.1007/s003300050964 [DOI] [PubMed] [Google Scholar]
- 15. Mignarri A, Dotti MT, Del Puppo M, et al. Cerebrotendinous xanthomatosis with progressive cerebellar vacuolation: six‐year MRI follow‐up. Neuroradiology. 2012;54(6):649‐651. doi: 10.1007/s00234-012-1026-8 [DOI] [PubMed] [Google Scholar]
- 16. Díaz‐Fontdevila M, Bustos‐Obregón E, Fornés M. Distribution of filipin‐sterol complexes in sperm membranes from hypercholesterolaemic rabbits. Andrologia. 1992;24(5):279‐283. doi: 10.1111/j.1439-0272.1992.tb02653.x [DOI] [PubMed] [Google Scholar]
- 17. Yamamoto Y, Shimamoto K, Sofikitis N, Miyagawa I. Effects of hypercholesterolaemia on Leydig and Sertoli cell secretory function and the overall sperm fertilizing capacity in the rabbit. Hum Reprod. 1999;14(6):1516‐1521. doi: 10.1093/humrep/14.6.1516 [DOI] [PubMed] [Google Scholar]
- 18. Sebastian SM, Selvaraj S, Aruldhas MM, Govindarajulu P. Pattern of neutral and phospholipids in the semen of normospermic, oligospermic and azoospermic men. J Reprod Fertil. 1987;79(2):373‐378. doi: 10.1530/jrf.0.0790373 [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Data Availability Statement
Data sharing is not applicable to this article as no new data were created or analyzed in this study.
